IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q4 2025 Holdings

Filed 2026-02-17 | 7 holdings | $229.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N.V.(PHVS)COMN69605108$132.6M4,778,58157.7%
Cytokinetics Inc(CYTK)COM23282W605$29.1M458,29512.7%
Lyell Immunopharma, Inc.(LYEL)COM55083R203$24.6M800,39910.7%
Maze Therapeutics, Inc.(MAZE)COM578784100$21.7M522,6579.4%
Relay Therapeutics, Inc.(RLAY)COM75943R102$8.5M1,000,0003.7%
Xenon Pharmaceuticals Inc.(XENE)COM98420N105$7.2M160,0003.1%
Alector, Inc.(ALEC)COM014442107$6.1M3,887,2002.6%